Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.49% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 8.01% |
| 4 | Financials | 6.79% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Capital City Bank Group
CCBG
$879M
| $981K | ﹤0.01% |
34,501
-33,164
| -49% | -$900K |
|
4002
NNN REIT
NNN
$8.76B
| $980K | ﹤0.01% |
23,016
+6,987
| +44% | +$291K |
|
4003
PUT
Eastman Chemical
EMN
$8.38B
| $980K | ﹤0.01% |
+10,000
| New | +$992K |
|
|
OSG
4004
Octave Specialty Group
OSG
$208M
| $973K | ﹤0.01% |
75,860
+18,594
| +32% | +$284K |
|
4005
CALL
BlackLine
BL
$1.9B
| $969K | ﹤0.01% |
20,000
+8,000
| +67% | +$439K |
|
|
BRSL
4006
PUT
Brightstar Lottery PLC
BRSL
$2.13B
| $968K | ﹤0.01% |
47,300
-26,000
| -35% | -$531K |
|
4007
HighPeak Energy
HPK
$1.02B
| $967K | ﹤0.01% |
68,806
-135,887
| -66% | -$2.01M |
|
4008
Coastal Financial
CCB
$741M
| $967K | ﹤0.01% |
20,951
-77,299
| -79% | -$3.25M |
|
4009
Century Therapeutics
IPSC
$366M
| $966K | ﹤0.01% |
378,633
+21,232
| +6% | +$67.1K |
|
4010
Moody's
MCO
$89.2B
| $965K | ﹤0.01% |
2,292
-70,276
| -97% | -$28M |
|
4011
CALL
Strategy Inc
MSTR
$50.7B
| $964K | ﹤0.01% |
7,000
-38,000
| -84% | -$5.48M |
|
4012
5E Advanced Materials
FEAM
$66.8M
| $964K | ﹤0.01% |
34,635
+33,563
| +3,131% | +$1.05M |
|
4013
CALL
BJs Wholesale Club
BJ
$11.5B
| $957K | ﹤0.01% |
10,900
-100
| -0.9% | -$8.1K |
|
4014
Valaris
VAL
$6.02B
| $957K | ﹤0.01% |
12,839
+1,578
| +14% | +$114K |
|
|
HIVE
4015
HIVE Digital Technologies
HIVE
$760M
| $956K | ﹤0.01% |
309,373
-108,334
| -26% | -$304K |
|
4016
PUT
M&T Bank
MTB
$34.4B
| $954K | ﹤0.01% |
6,300
-20,900
| -77% | -$3.05M |
|
4017
CALL
Amneal Pharmaceuticals
AMRX
$6.13B
| $953K | ﹤0.01% |
150,000
-50,000
| -25% | -$317K |
|
4018
PUT
International Paper
IP
$20.9B
| $949K | ﹤0.01% |
22,000
-102,100
| -82% | -$4.15M |
|
4019
Protalix BioTherapeutics
PLX
$205M
| $949K | ﹤0.01% |
811,160
+800,676
| +7,637% | +$946K |
|
|
WOW
4020
DELISTED
WideOpenWest
WOW
| $947K | ﹤0.01% |
175,086
+97,188
| +125% | +$431K |
|
4021
Novartis
NVS
$291B
| $944K | ﹤0.01% |
8,863
-262,380
| -97% | -$26.3M |
|
|
EGRX
4022
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $940K | ﹤0.01% |
167,782
-90,082
| -35% | -$392K |
|
4023
CALL
British American Tobacco
BTI
$121B
| $937K | ﹤0.01% |
30,300
-73,700
| -71% | -$2.24M |
|
4024
PUT
Regions Financial
RF
$25.9B
| $936K | ﹤0.01% |
46,700
-21,600
| -32% | -$419K |
|
4025
Security National Financial
SNFCA
$230M
| $935K | ﹤0.01% |
135,500
+115,992
| +595% | +$738K |
|
Similar funds
Israel Englander's Q2 2024 Portfolio in Review
As of Q2 2024, Israel Englander held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2024 filing shows 661 new, 2,109 increased, 2,549 reduced and 995 closed positions. Its largest new stake was QXO Inc: 2,219,158 shares worth $20.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $963M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Israel Englander's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Israel Englander fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Israel Englander's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Israel Englander opened 661 new positions and closed 995 in Q2 2024.
- Israel Englander's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.